pentobarbital will lessen the extent or influence of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Use of different therapies is strongly proposed when linagliptin is to be administered with a CYP3A4 inducerpentobarbital will minimize the level or influence of theophylline by affecting hepatic/intestinal e